Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome

Annals of Oncology

Volumn 19, Issue 4, 2008, Pages 774-779

  Thieblemont, Catherine ^a   Grossoeuvre, A ^b,c   Houot, R ^b,c   Broussais Guillaumont, F ^b,c   Salles, G ^b,c   Traulle C ^b,c   Espinouse, D ^b,c   Coiffier, B ^b,c  

^a SAINT LOUIS HOSPITAL   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Comorbities; Lymphoma; Prognostic factors; Very elderly patients

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; LACTIC ACID; PREDNISONE; RITUXIMAB; VINCRISTINE;

AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL FEATURE; COMBINATION CHEMOTHERAPY; COMORBIDITY; DISEASE COURSE; FEBRILE NEUTROPENIA; FEMALE; HISTOPATHOLOGY; HUMAN; LACTATE BLOOD LEVEL; LARGE B CELL LYMPHOMA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 41549137352     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm563     Document Type: Article

References (28)

1. Murray C, Lopez A. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
2. Jemal A, Siegel R, Ward E et al. Cancer statistics. 2007. CA Cancer J Clin 2007; 57: 43-66.
3. Weisenburger DD. Epidemiology of non-Hodgkin's lymphoma: Recent findings regarding an emerging epidemic. Ann Oncol 1994; 5 (Suppl 1): 19-24.
4. Balducci L, Extermann M. Cancer and aging. An evolving panorama. Hematol Oncol Clin North Am 2000; 14: 1-16.
5. Hoerni B, Sotto JJ, Eghball H et al. Non-Hodgkin's malignant lymphomas in patients older than 80: 70 cases. Cancer 1988; 61: 2057-2059.
6. The Non-Hodgkin's Lymphoma Classification Project. Effect of age on the characteristics and clinical behavior of non-Hodgkin's lymphoma patients. Ann Onool 1997; 8: 973-978.
7. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242.
8. Habermann TM, Weller EA, Morrison VA et al. Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 2006; 24: 3121-3127.
9. Dixon DO, Neilan B, Jones SE et al. Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: The Southwest Oncology Group experience. J Clin Oncol 1986; 4: 295-305.
10. Gomez H, Mas L, Casanova L et al. Elderly patients with aggressive non-Hodgkin's lymphoma treated with CHOP chemotherapy plus granulocyte-macrophage colony-stimulating factor: Identification of two age subgroups with differing hematologic toxicity. J Clin Oncol 1998; 16: 2352-2358.
11. Neilly IJ, Ogston M, Bennett B, Dawson AA. High grade non-Hodgkin's lymphoma in the elderly - 12 year experience in the Grampian Region of Scotland. Hematol Oncol 1995; 13: 99-106.
12. Vose JM, Armitage JO, Weisenburger DD et al. The importance of age in survived of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol 1988; 6: 1838-1844.
13. d'Amore F, Brincker H, Christensen BE et al. Non-Hodgkin's lymphoma in the elderly. A study of 602 patients aged 70 or older from a Danish population-based registry. The Danish LYEO-Study Group. Ann Oncol 1992; 3: 379-386.
14. Bastion Y, Blay JY, Divine M et al. Elderly patients with aggressive non-Hodgkin's lymphoma: Disease presentation, response to treatment, and survival - a Groupe d'Etude des Lymphomes de l'Adulte study on 453 patients older than 69 years. J Clin Oncol 1997; 15: 2945-2953.
15. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hemalopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
16. Reuben D. Correlates of hypoalbuminemia in community-dwelling older persons. Am J Clin Nutr 1997; 66: 38-45.
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987; 40: 373-383.
18. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987-994.
19. Cheson B, Homing S, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphoma. J Clin Oncol 1999; 17: 1244-1253.
20. Maartense E, Hermans J, Kluin-Nelemans J et al. Elderly patients with non-Hodkgin's lymphoma: Population-based results in the Netherlands. Ann Oncol 1998; 9: 1219-1227.
21. Groves F, Linet M, Travis L, Devesa S. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtypes in the united states from 1978 through 1995. J Natl Cancer Inst 2000; 92: 1240-1251.
22. Staudt LM. Molecular diagnosis of the hematologic cancers. N Engl J Med 2003; 348: 1777-1785.
23. Extermann M, Aapro M, Bernabei R et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005; 55: 241-262.
24. Repetto, L, Fratino L, Audisio RA et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology study. J Clin Oncol 2002; 20: 494-502.
25. van Spronsen DJ, Janssen-Heijnen MLG, Breed WPM, Coebergh JWW. Prevalence of co-morbidity and its relationship to treatment among unselected patients with Hodgkin's disease and non-Hodgkin's lymphoma, 1993-1996. Ann Hematol 1999; 78: 315-319.
26. Lyman GH, Dale DC, Friedberg J et al. Incidence and predictors of low chemotherapy dose-intensity in aggressive non-Hodgkin's lymphoma: A nationwide study. J Clin Oncol 2004; 22: 4302-4311.
27. Tirelli U, Carbone A, Monfardini S, Zagonel V. A 20-year experience on malignant lymphomas in patients aged 70 and older at a single institute. Crit Rev Oncol Hematol 2001; 37: 153-158.
28. Zinzani PL, Storti S, Zaccaria A et al. Elderly aggressive-histology non-Hodgkin's lymphoma: First-line VNCOP-B regimen experience on 350 patients. Blood 1999; 94: 33-38.